2014年美国胸外科医师协会《食管及胃食管连接处癌多学科综合治疗临床实践指南》解读  

Re-evaluating multimodality treatment for cancer of the esophagus and gastroesophageal junction:an Interpretation of the 2014 practice guidelines from the society of thoracic surgeons

作　　者：熊鹏[1] 桑海威 朱珉[1] 付向宁[1] 

机构地区：[1]华中科技大学同济医学院同济医院胸外科

出　　处：《临床外科杂志》2015年第8期634-636,共3页Journal of Clinical Surgery

摘　　要：我国是食管癌的高发区，位于恶性肿瘤发病率和死亡率的前5位。根据循证医学原则，以手术为主，结合放化疗、生物治疗、姑息治疗的综合治疗，是改善预后的有益策略。近日美国胸外科医师协会发表了新的指南，现拟结合我国实际情况对该指南予以解读。Esophagus cancer is a common tumor of digestive tract and its incidence rank eight of all malignant tumors. China is the high incidence area of esophagus cancer, ranking top five of malignant tumors in its incidence and mortality rate. Muhimodality treatment has been to be a benefit strategy for improving prognosis based on evidence-based medicine, which gives priority to surgery combined with radiochemotherapy and biological therapy and palliative treatment. This article shows the understanding of the new guidelines of The Society of Thoracic Surgeons（STS） in coordination with situation in China.

关 键 词：食管癌 胃食管连接处癌 综合治疗 指南 解读 

分 类 号：R735.1[医药卫生—肿瘤]